Healthcare -
Biotechnology - NASDAQ - US
$ 43.84
1.76 %
$ 3.38 B
Market Cap
-7.38
P/E
PTCT - STOCK-BASED COMPENSATION
Stock-based Compensation PTCT - PTC Therapeutics, Inc.
131 M
LAST VALUE
12.58%
2 YEAR CAGR
31.59%
5 YEAR CAGR
31.59%
10 YEAR CAGR